China Pharma Holdings (CPHI) has released an update.
China Pharma Holdings, Inc. announced a 1-for-5 reverse stock split scheduled to take effect on March 6, 2024. This adjustment means that every five shares of existing stock will be consolidated into one new share. The change will start with the opening of the market on the effective date, with all shares having the same par value of $0.001. This strategic move aims to restructure the company’s stock for improved market performance.
For further insights into CPHI stock, check out TipRanks’ Stock Analysis page.
